Lv11
20 积分 2024-05-22 加入
CAR T therapy beyond cancer: the evolution of a living drug
1小时前
已完结
Engineered receptors for soluble cellular communication and disease sensing
2小时前
已完结
Overexpression of an Engineered SerpinB9 Enhances Allogeneic T-Cell Persistence and Efficacy
14天前
已完结
Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy
2个月前
已完结
Autoimmune disease is the next frontier for CAR T cell therapy
4个月前
已完结
A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells
4个月前
已完结
Forks in the road for CAR T and CAR NK cell cancer therapies
6个月前
已完结
皖公网安备34019202002308
